Pomalidomide Chemical Structure (Pomalyst 01)
Pomalyst Capsule
Product Images NDC 59572-503
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Pomalyst (NDC 59572-503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Celgene Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Progression Free Survival Based On Irac Review Of Response By Imwg Criteria (Pomalyst 02)
Kaplan-meier Curve Of Overall Survival (Pomalyst 03)
Pomalyst (pomalidomide) Capsules, 1 mg (21 Count Bottle Label)
This is a description of the drug Pomalyst, which is available in capsule form. It warns of the potential for human birth defects and advises storage at a controlled temperature range. It also mentions the manufacturer's location as Switzerland and the need to consult the prescribing information before use. The medication guide needs to be dispensed along with the capsules.*
Pomalyst (pomalidomide) Capsules, 1 mg (100 Count Bottle Label)
This is a drug called N, with the NDC code 59572-501-00. It comes in the form of capsules with a dosage of 1mg and is only available with a prescription. The drug is manufactured by Celgene Corporation in Switzerland and comes in a bottle of 100 capsules. It is recommended to store the product at a temperature of 20°C to 25°C but can tolerate excursions of between 15°C to 30°C, and the packaging also complies with the USP controlled room temperature guidelines. The label also indicates that prescribing information should be consulted before use, and medication guides should be dispensed with it. There is no further information available, such as what the drug is intended to treat or its potential side effects.*
Pomalyst (pomalidomide) Capsules, 2 mg (21 Count Bottle Label)
A Pomalyst capsule is a prescription medication manufactured by Celgene Corporation. It is used for human consumption, but there is a warning of its potential effects. The medication should be stored at a temperature range of 20°C - 25°C (68°F - 77°F) with excursions allowed up to 15°C - 30°C (59°F - 86°F), as indicated by the USP Controlled Room Temperature. The medication guide must be dispensed with the product. For further information about dosing and administration, one must consult the prescribing information.*
Pomalyst (pomalidomide) Capsules, 2 mg (100 Count Bottle Label)
This is a medication called Pomalyst, which comes in capsule form and is only available by prescription. It has the potential for causing birth defects and should be stored within a specific temperature range. It is manufactured by Celgene Corporation and made in Switzerland. It is important to refer to the prescribing information for dosing and administration, and the medication guide should be dispensed.*
Pomalyst (pomalidomide) Capsules, 3 mg (21 Count Bottle Label)
This is a prescription-only medication labeled "Pomalyst" with an NDC code of 59572-503-21. The medication comes in the form of capsules and there is a warning of potential harm to humans. The capsules should be stored within the temperature range of 20°C - 25°C (68°F - 77°F), with excursions permitted to 15°C - 30°C (59°F - 86°F). Notably, the manufacturer is Celgene Corporation and it was made in Switzerland. Precise dosing and administration information can be obtained from the prescribing information while the medication dispenses with Modification Guide.*
Pomalyst (pomalidomide) Capsules, 3 mg (100 Count Bottle Label)
This is a description of a medication called Pomalyst. The medication is in the form of capsules and comes in a container with 100 capsules. The medication is only available with a prescription. The container should be stored in a controlled room temperature between 20°C - 25°C (68°F - 77°F), with permitted excursions of 15°C - 30°C (59°F - 86°F). The manufacturer of the medication is Celgene Corporation, located at 86 Morris Avenue in Summit, NJ. The medication may cause birth defects and therefore caution should be exercised. More information regarding dosing and administration can be found in the prescribing information. The packaging contains an NDC number of 59572-503-00.*
Pomalyst (pomalidomide) Capsules, 4 mg (21 Count Bottle Label)
NDC 59572-504-21 is a prescription medication called "Pomalyst" used for treating certain types of cancer. The medication comes in capsule form and should be stored between 20°C - 25°C (68°F - 77°F). Celgene Corporation manufactured the drug in Switzerland in 2013-2015. There are dosing and administration guidelines for this medication, and it should be dispensed with a medication guide. Excursions permitted to 15°C - 30°C. For more information, please consult the prescribing information.*
Pomalyst (pomalidomide) Capsules, 4 mg (100 Count Bottle Label)
This is a description of a prescription medication called Pomalyst. It comes in capsule form and is only available with a prescription. The medication should be stored at a temperature between 20°C - 25°C with excursions allowed between 15°C - 30°C, and it should be dispensed with a medication guide. The medication is manufactured by Celgene Corporation in Switzerland. Further dosing and administration information can be found on the prescribing information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
